The predictive value of EGF A61G gene polymorphism in third-line treatment with cetuximab and irinotecan of patients with metastatic colorectal cancer

Karen-Lise Garm Spindler, Anders Jakobsen

Research output: Contribution to conference without publisher/journalPosterResearch

Original languageEnglish
Publication date2008
Publication statusPublished - 2008
EventDSKO's Årsmøde - Vejle, Denmark
Duration: 10. Apr 200810. Apr 2008

Conference

ConferenceDSKO's Årsmøde
CountryDenmark
CityVejle
Period10/04/200810/04/2008

Cite this